You have searched for "Hetero"
Showing 1-10 of 28
PUNE, India/NEW DELHI (Reuters) - India, the world's biggest vaccine maker, is getting set for the massive global blitz to contain the coronavirus pandemic with its pharmaceutical industry and partners freeing up capacity and accelerating investments even without firm purchase orders.
(Reuters) - Several Indian pharmaceutical companies are working to develop or manufacture at least eight anti-COVID-19 formulations as the world's largest producer of vaccines prepares for a massive response to the coronavirus pandemic.
MOSCOW (Reuters): Indian pharmaceutical company Hetero will manufacture over 100 million doses of the Russian Sputnik V Covid-19 vaccine per year under the terms of a deal unveiled on Friday (Nov 27) between it and Russia’s RDIF sovereign wealth fund.
MOSCOW (Reuters) - Indian pharmaceutical company Hetero will manufacture over 100 million doses of the Russian Sputnik V COVID-19 vaccine per year under the terms of a deal unveiled on Friday between it and Russia's RDIF sovereign wealth fund.
Indonesia approves emergency use of antiviral drugs to treat Covid-19 patients as death toll hits 11,371
JAKARTA, Oct 6 (The Jakarta Post/ANN): Indonesia's Food and Drug Monitoring Agency (BPOM) has issued emergency use authorisation (EUA) for two antiviral drugs, favipiravir and remdesivir, to treat COVID-19 patients.
MUMBAI (Reuters) - India reported over 49,000 fresh cases of the novel coronavirus with 740 new deaths on Friday, marking the biggest daily surge in cases even as officials in some states complained of shortages of vital drugs for those hospitalized.
(Reuters) - Gilead Sciences Inc
BUDAPEST (Reuters) - Advertisements by Coca-Cola around a music festival in Hungary that promote gay acceptance have prompted a boycott call from a senior member of the conservative ruling party.
SHANGHAI/LONDON (Reuters) - A toxin inadvertently produced in the manufacture of a widely prescribed medicine but not spotted for years raises questions about regulators' ability to detect risks in a sprawling global drug supply chain increasingly reliant on factories in China.
BANGKOK: An LGBTIQ rights group has called for changes to the Gender Equality Act to improve enforcement of the law, noting that it took over a year for action to be taken on a clear case of gender injustice – and even then the response was too weak.